J. Safra Sarasin Holding AG

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1890222 BASEL, V8

Position in VRTX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$2,083,782

+$210,547 QoQ

Shares Held

4,195

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#668

of 1,742 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

J. Safra Sarasin Holding AG holds $38,071,978 across 30 Biotechnology names. VRTX ranks #4 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	95,602	$10,193,085
2	INCY	Incyte Corp	29,655	$3,361,690
3	ALNY	Alnylam Pharmaceuticals, Inc.	7,921	$2,384,458
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	4,195	$2,083,782
5	VERA	Vera Therapeutics, Inc.	47,662	$2,045,176
6	VRDN	Viridian Therapeutics, Inc.\DE	107,839	$1,981,002
7	ROIV	Roivant Sciences Ltd.	49,694	$1,758,670
8	RPRX	Royalty Pharma plc	30,662	$1,719,217

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,083,782	4,195	0.0%	Shares	Defined	2026-07-31
2026-03-31	$1,873,235	4,195	+39.8%	Shares	Defined	2026-05-04
2025-12-31	$1,360,080	3,000	-21.6%	Shares	Defined	2026-01-15
2025-09-30	$1,498,806	3,827	+27.6%	Shares	Defined	2025-11-03
2025-06-30	$1,335,600	3,000	-24.0%	Shares	Defined	2025-07-21
2025-03-31	$1,913,099	3,946	-92.9%	Shares	Defined	2025-05-09
2024-12-31	$22,509,316	55,896	-7.1%	Shares	Defined	2025-02-14
2024-09-30	$27,970,840	60,142	-11.1%	Shares	Defined	2024-11-12
2024-06-30	$31,694,843	67,620	—	Shares	Defined	2024-07-30
No filing history on record for this holder in this stock.